Genetic polymorphisms of glutathione S-transferase A1, the major glutathione S-transferase in human liver: consequences for enzyme expression and busulfan conjugation
- PMID: 12087351
- DOI: 10.1067/mcp.2002.124518
Genetic polymorphisms of glutathione S-transferase A1, the major glutathione S-transferase in human liver: consequences for enzyme expression and busulfan conjugation
Abstract
Background: High-dose busulfan is widely used as part of conditioning regimens for patients who are undergoing hematopoietic stem cell or bone marrow transplantation. High plasma concentrations of busulfan have been linked to the occurrence of hepatic venoocclusive disease (VOD), a severe complication associated with a high mortality. Because conjugation with glutathione, the major route of biotransformation of busulfan, is predominantly catalyzed by the isozyme glutathione S-transferase A1 (GSTA1), we hypothesized that low expression or function of GSTA1 in liver caused by genetic polymorphisms may be the mechanism underlying VOD.
Methods: Immunoblot analysis of GSTA and measurement of busulfan-glutathione conjugation by liquid chromatography-mass spectrometry were performed in 48 normal human liver samples. To search for polymorphisms, the complete GSTA1 coding regions and the promoter fragment were sequenced. All results were compared by multivariate analysis.
Results: Absolute levels of GSTA protein and formation rates of busulfan-glutathione conjugate displayed a 7- and 8-fold range, from 240 to 1600 pmol/mg and 25 to 205 pmol/min per milligram of total cytosolic protein, respectively, and correlate (r2 = 0.49, P <.0001). A total of 8 single nucleotide polymorphisms (SNPs) of GSTA1 were identified, 1 of which was a silent mutation in exon 5 (A375G); all others were found in the promoter region. Haplotype analysis revealed the existence of 5 defined alleles. There was no significant relationship between any of the GSTA1 SNPs or haplotypes and either hepatic glutathione S-transferase A (GSTA) expression or GSTA1 function.
Conclusions: The identified GSTA1 polymorphisms are not likely to be related to the VOD because they do not appear to be associated with changes in GSTA expression or function. Compared with other members of the GST family, GSTA1 displays surprisingly little variation.
Similar articles
-
Glutathione S-transferase A1 polymorphisms and acute graft-vs.-host disease in HLA-matched sibling allogeneic hematopoietic stem cell transplantation.Clin Transplant. 2007 Mar-Apr;21(2):207-13. doi: 10.1111/j.1399-0012.2006.00624.x. Clin Transplant. 2007. PMID: 17425746
-
Influence of glutathione S-transferase A1 polymorphism on the pharmacokinetics of busulfan.Clin Chim Acta. 2006 Jun;368(1-2):93-8. doi: 10.1016/j.cca.2005.12.011. Epub 2006 Jan 31. Clin Chim Acta. 2006. PMID: 16448639 Clinical Trial.
-
Glutathione S-transferase polymorphisms are not associated with population pharmacokinetic parameters of busulfan in pediatric patients.Ther Drug Monit. 2008 Aug;30(4):504-10. doi: 10.1097/FTD.0b013e3181817428. Ther Drug Monit. 2008. PMID: 18641537
-
Effect of glutathione S-transferase genetic polymorphisms on busulfan pharmacokinetics and veno-occlusive disease in hematopoietic stem cell transplantation: A meta-analysis.Basic Clin Pharmacol Toxicol. 2019 Jun;124(6):691-703. doi: 10.1111/bcpt.13185. Epub 2018 Dec 25. Basic Clin Pharmacol Toxicol. 2019. PMID: 30511436
-
Human alpha class glutathione S-transferases: genetic polymorphism, expression, and susceptibility to disease.Methods Enzymol. 2005;401:9-42. doi: 10.1016/S0076-6879(05)01002-5. Methods Enzymol. 2005. PMID: 16399377 Review.
Cited by
-
Population Pharmacokinetics and Optimal Sampling Strategy for Model-Based Precision Dosing of Melphalan in Patients Undergoing Hematopoietic Stem Cell Transplantation.Clin Pharmacokinet. 2018 May;57(5):625-636. doi: 10.1007/s40262-017-0581-x. Clin Pharmacokinet. 2018. PMID: 28918602 Clinical Trial.
-
Polymorphism of CYP3A4*18 is associated with anti-tuberculosis drug-induced hepatotoxicity.Pharmacogenomics. 2024;25(5-6):241-247. doi: 10.1080/14622416.2024.2346069. Epub 2024 May 10. Pharmacogenomics. 2024. PMID: 38884784 Free PMC article.
-
The analysis of GSTA1 promoter genetic and functional diversity of human populations.Sci Rep. 2021 Mar 3;11(1):5038. doi: 10.1038/s41598-021-83996-2. Sci Rep. 2021. PMID: 33658540 Free PMC article.
-
Glutathione S-transferase A1 genetic variants reduce busulfan clearance in children undergoing hematopoietic cell transplantation.J Clin Pharmacol. 2008 Sep;48(9):1052-62. doi: 10.1177/0091270008321940. Epub 2008 Jul 17. J Clin Pharmacol. 2008. PMID: 18635758 Free PMC article.
-
Frequencies of 23 functionally significant variant alleles related with metabolism of antineoplastic drugs in the chilean population: comparison with caucasian and asian populations.Front Genet. 2012 Nov 2;3:229. doi: 10.3389/fgene.2012.00229. eCollection 2012. Front Genet. 2012. PMID: 23130019 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials